The statement added: “The Singapore Government’s stand on illicit drugs, including cannabis, is clear – they are harmful, addictive and can destroy lives, families and communities.”
In the statement, the ministries said Singapore’s “comprehensive and sustained approach” to tackling both the demand and supply of drugs has allowed the country to remain relatively drug-free.
These cannabinoid pharmaceuticals undergo rigorous scientific review by the Health Sciences Authority before they can be registered for supply here.
“There is some published research, derived from controlled clinical trials, on the potential therapeutic uses of cannabinoids to manage seizures and epilepsy,” added the statement.
It said examples of other countries have clearly shown that a permissive attitude towards the use of drugs exacts a high cost on society.
In a joint statement on Wednesday (Feb 13), the Ministry of Home Affairs and the Health Ministry said it was important to differentiate between products containing unprocessed or raw cannabis and pharmaceutical products containing cannabinoids.
However, to date, there have been no studies which validate the claims of unprocessed or raw cannabis being able to treat medical conditions, said the authorities.
“Therefore, we have strict laws against the trafficking, possession, consumption, and import or export of illicit drugs, including cannabis and cannabis products.”
CBD is derived from the cannabis plant, but its regulatory status has not been clearly defined prior to this announcement. Other derivatives from the cannabis plant, such as cannabinol, cannabinol derivatives, cannabis, and cannabis resin are listed in the Class A controlled drug list.
“While the new update suggests the possibility of CBD being registered as medicinal product, I do not think it will be accepted as a health supplement or nutraceutical ingredient in the near future.
“[CBD is] not to be used in health supplements. It is developed for use in medicines. Known to affect the mental state,” HSA said in the guidelines.
The announcement has clarified the status of CBD in Singapore, said Poon Wai Mun, regulatory affairs consultant at Wong SJ Asia.
The announcement can also be interpreted as a confirmation by the HSA on the prohibition of CBD use in health supplements, Wong said, adding that it was unlikely for CBD to be permitted for use in health supplements in the near term.
The hemp plant. ©Getty Images
“The regulatory status of CBD wasn’t clearly stated in any of the [existing] regulations, though we know it wasn’t permitted. This new update of the Health Supplements Guidelines has provided clarity on its regulatory status,” she told NutraIngredients-Asia.
Singapore’s Health Science Authority (HSA) recently made announcements on CBD’s regulatory status in its revised Health Supplements Guidelines.
Below is Part 1 of our fascinating and highly informative interview. Don’t forget to read Part 2.
What Exactly Is CBD?
It’s important to note that THC and its derivatives are illegal in Hong Kong and anything containing these substances is prohibited. When purchasing CBD products, it is important to look at labels or ask the seller to make sure you are purchasing Broad Spectrum CBD or CBD Isolate-based products to avoid unintentionally breaching the law.
Can I Travel With CBD?
CBD is legal in Hong Kong. According to several official government press announcements, CBD (cannabidiol) is not classified as a dangerous drug and is therefore not controlled under the Dangerous Drugs Ordinance.